OCTAPHARMA USA INC

OCTAPHARMA USA INC specializes in the manufacturing of biological products and pharmaceutical preparations for federal medical systems, with a focus on plasma-derived therapeutics and hematologic agents. The company’s technical expertise lies in aseptic processing, viral inactivation, and quality-controlled production of human-derived biologics, including plasma fractionation and lyophilized pharmaceutical formulations. Their capability in producing specialized products such as OCTAPLAS® LG demonstrates advanced proficiency in cold-chain logistics, sterility assurance, and compliance with cGMP standards for high-risk biologics. Differentiators include deep domain knowledge in plasma protein purification and hemostatic agent manufacturing, positioning them as a niche supplier for mission-critical blood product needs in defense and veteran healthcare environments. The contractor has delivered products to the Department of Defense and the Department of Veterans Affairs, supplying specialized pharmaceuticals for field medical units and VA pharmacy systems. Work with DoD centers on life-saving biologics for combat medicine and emergency medical units, while VA engagements center on long-term pharmaceutical supply chains for chronic condition management, particularly in hematology and transfusion medicine. These relationships reflect a pattern of trusted, mission-aligned procurement for specialized, non-commoditized therapeutics. OCTAPHARMA USA INC operates primarily under NAICS 325414 and 325412, indicating direct involvement in the production of biological therapeutics and sterile pharmaceutical preparations. The company serves the high-barrier biopharmaceutical segment, focusing on complex, regulated products requiring stringent process validation and traceability—areas where few suppliers meet federal standards. Their market positioning is that of a specialized manufacturer rather than a broad-line distributor. As a 2L entity based in Paramus, New Jersey, OCTAPHARMA USA INC is structured as a subsidiary of a global biopharmaceutical firm with established manufacturing infrastructure. While no federal certifications are listed, their consistent production of FDA-regulated biologics for defense and veteran healthcare implies adherence to rigorous quality systems. Their geographic footprint supports federal logistics networks along the Northeast corridor, enabling reliable distribution to high-priority federal medical facilities.